Correspondingly, individuals with T1D have been found to exhibit reduced levels of circulating TRAIL, particularly around disease onset, suggesting a deficiency of this protective apoptotic signal during the autoimmune attack on β cells [61]. This evidence concerns the gene TNFSF10 and type 1 diabetes mellitus.